Passive Immunity to SARS-CoV-2 at Birth Induced by Vaccination in the First Trimester of Pregnancy임신 첫 3개월 동안 예방 접종으로 유도된 출생 시 SARS-CoV-2에 대한 수동 면역Case Reports Published on 2021-12-032022-09-12 Journal: International Journal of Environmental Research an [Category] SARS, 진단, [키워드] affecting anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody approach automated Birth Blood carried collected Complete COVID-19 infection DELFIA described Filter Paper first trimester Health IgG antibodies IgG antibody immune response immune system immunoassay induced invasive life Mild MONITOR mother Newborn newborn SARS-CoV-2 immunity Passive performed position Pregnancy pregnant women SARS-CoV-2 screening program Serological assay serological test solid phase spike-specific T cells trimester vaccination vaccination in pregnancy viral infection virus woman [DOI] 10.3390/ijerph182312789 PMC 바로가기 [Article Type] Case Reports
Routine COVID-19 testing may not be necessary for most cancer patients대부분의 암 환자에게는 일상적인 covid-19 검사가 필요하지 않을 수 있습니다.Comparative Study Published on 2021-12-022022-09-01 Journal: Scientific Reports [Category] 진단, 치료법, [키워드] age Analysis antibody tests average average age benefit Cancer cancer patient Cancer patients Comorbidities Comorbidity COVID-19 COVID-19 antibody tests COVID-19 infection COVID-19 testing death eligible evaluated group individual Infectious diseases less molecular Multivariate analysis negative and positive no significant difference Older age P -value Patient patients PCR test positive positive RT-PCR Probability random Random sample recruited risk routine RT-PCR screening tests serological test Serological tests severe complication severe complications significant difference significantly lower subgroup of patient subject test result tested [DOI] 10.1038/s41598-021-02692-3 PMC 바로가기 [Article Type] Comparative Study
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors무증상 헌혈자의 SARS-CoV-2 감염 경향 및 위험인자Article Published on 2021-12-012022-09-11 Journal: Transfusion [Category] MERS, SARS, 진단, 치료기술, [키워드] ABO ABO blood group absence Anemia anti-nucleoprotein anti-RBD Anti-RBD antibodies Anti-RBD antibody Anti-spike antibodies antibody Asymptomatic baseline Blood blood donor Blood donors Blood Group Blood groups carrier carriers COVID-19 declined develop disease domain Donor Epidemiology Factor ferritin Follow-up General population groups healthy blood donor healthy blood donors help immunization increase in individual infected individuals Infection Italy Nasopharyngeal swab nasopharyngeal swab PCR participant persistence positive positive PCR presenting Prevalence proportion RBD risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected individual SARS-CoV-2-infected individuals screened second wave Seroconversion serological test Serological tests Seroprevalence severe symptoms short-lived Spread tested trend vaccination Viremia [DOI] 10.1111/trf.16693 PMC 바로가기 [Article Type] Article
Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report급성 중증 궤양성 대장염 및 코로나바이러스 질환 2019에 이어 대장균 0157:H7 감염 환자에서 Infliximab 구조 요법: 증례 보고Case Reports Published on 2021-12-012022-09-12 Journal: Croatian Medical Journal [Category] 진단, [키워드] administration antibiotic Antibiotic treatment biologic Case report caused clinical response coronavirus disease COVID-19 disease dominant driven by Escherichia coli general condition induce Infection Inflammatory bowel disease infliximab management Mild Necrosis parameter Patient positive risk SARS-CoV-2 SARS-CoV-2-positive patient second serological test severity tested the patient therapy treat treated Treatment ulcerative colitis uremic syndrome [DOI] 10.3325/cmj.2021.62.634 PMC 바로가기 [Article Type] Case Reports
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants상업용 Anti-SARS-CoV-2 수용체 결합 도메인 항체 테스트와 화학발광 환원 중화 테스트의 상관관계 및 항체의 새로운 변이체 검출 가능Research Article Published on 2021-12-012022-09-10 Journal: Microbiology Spectrum [Category] SARS, 변종, 진단, 치료기술, [키워드] 95% confidence interval Accuracy acquisition acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 anti-RBD anti-receptor-binding domain Antibody test antibody test result antibody tests B.1.1.7 B.1.351 B.1.351 variant B.1.351 variants biohazard clinical laboratory close contact comparable convalescent convalescent COVID-19 patients convalescent phase Coronavirus-2 correlated correlation COVID-19 COVID-19 patient COVID-19 patients Critical defined detection diagnostic disease onset displaying Efficacy episode episode of Evidence evidence of functional healthy individual high throughput identify immune response Immunity indicate Laboratory lead neutralization Neutralizing Neutralizing activity Neutralizing antibodies Neutralizing titer neutralizing titers optimization Patient PCR-negative positive result proof protective immunity provide Pseudotyped virus Pseudotyped viruses Quantitative RBD Receptor-binding domain recognizing reduction respiratory SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Seroconversion serological test Serological tests serology serum sample serum samples Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Spike protein Strong symptomatic Test test validity Vaccine vaccine efficacy Validity variant variants virus viruses wild-type [DOI] 10.1128/Spectrum.00560-21 PMC 바로가기 [Article Type] Research Article
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men균질한 건강한 젊은 남성 집단에서 가벼운 SARS-CoV-2 감염 후 광범위하게 이질적인 체액성 및 세포성 면역Article Published on 2021-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] SARS, 진단, 치료기술, 치료법, [키워드] adaptive Adaptive immunity anti-nucleoprotein antibodies antibody Antibody detection cellular immunity cellular response Cellular responses Cohort conducted COVID-19 cross-sectional survey detect detectable Diagnosis Frequency healthy heterogeneity heterogeneous homogeneous humoral humoral and cellular immunity Humoral and cellular responses Humoral response humoral responses implication individual Infection magnitude median median age men Mild Mild disease mild SARS-CoV-2 infection Neutralizing antibodies nine observation Patient persistence recruited reduction SARS-CoV-2 SARS-CoV-2 protein serological test Serological tests South Asian spike study population Surveillance T cell T cell response T cells Vaccination strategies was tested were used with mild disease [DOI] 10.1080/22221751.2021.1999777 PMC 바로가기 [Article Type] Article
Electrochemical Capillary-Flow Immunoassay for Detecting Anti-SARS-CoV-2 Nucleocapsid Protein Antibodies at the Point of Care치료 시점에서 항-SARS-CoV-2 뉴클레오캡시드 단백질 항체를 검출하기 위한 전기화학적 모세관 흐름 면역분석법Article Published on 2021-11-262022-09-11 Journal: ACS Sensors [Category] MERS, SARS, 진단, 치료기술, 치료법, 치료제, [키워드] Accuracy anti-N antibodies anti-N antibody antibody Blood samples board capillary-flow device carbon Combination Device Diagnosis diagnostic reliability Electrochemistry ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay hydrophilic IgG antibodies IgG antibody immunoassay IMPROVE Infectious disease Infectious diseases integration Interpretation membrane near-field communication nitrocellulose Nitrocellulose membrane Nucleocapsid proteins performed plasma extraction POC Point point of care point-of-care point-of-care (POC) diagnostics polyester Protein Quantitative Rapid reagent reagents required SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 nucleocapsid serological test Serological tests serology Smartphone Surveillance Viral whole blood sample [DOI] 10.1021/acssensors.1c01527 PMC 바로가기 [Article Type] Article
Point-of-Care Diagnostic Tools for Surveillance of SARS-CoV-2 InfectionsSARS-CoV-2 감염 감시를 위한 현장 진단 도구Review Published on 2021-11-252022-09-11 Journal: Frontiers in Public Health [Category] MERS, SARS, 진단, 치료기술, [키워드] activities acute respiratory syndrome acute respiratory syndrome coronavirus Antigen cause Chain Reaction Clinical management clinical symptom Clinical symptoms confirmed COVID-19 case contagious coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 cases COVID-19 testing death diagnosed Diagnosis diagnostics early diagnosis effective infected individual infected individuals Isolation isothermal isothermal amplification (LAMP) molecular nucleic acid nucleic acid amplification point-of-care polymerase chain polymerase chain reaction protocol Public health intervention reported respiratory respiratory sample Respiratory samples reverse transcription reverse transcription polymerase chain reaction RT-PCR sample types SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections serological test Serological tests Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Spread Standard Surveillance Viral Viral RNA virus [DOI] 10.3389/fpubh.2021.766871 PMC 바로가기 [Article Type] Review
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 VaccineArticle Published on 2021-11-192022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] analyzed anti-S antibody Antibody titer B.1.1.7 B.1.351 variant BNT162b2 BNT162b2 vaccine COVID-19 COVID-19 vaccine D614G decrease detectable experiments first dose hcp Healthcare professional humoral immune response induce Infection Kinetics magnitude Month mRNA vaccine multicenter neutralization neutralization activity Prevent receiving Roche anti-SARS-CoV-2-S SARS-CoV-2 SARS-CoV-2 infections serological test seropositive individual serum antibody severe COVID-19 severe symptoms T 3 the antibody response the receptor-binding domain the SARS-CoV-2 the spike protein the vaccine threshold titer vaccination Vaccination strategies was tested were measured [DOI] 10.3390/vaccines9111357 PMC 바로가기 [Article Type] Article
Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection감염 후 13 개월 동안 SARS-COV-2- 특이 적 항체의 지속성Article Published on 2021-11-192022-09-01 Journal: Viruses [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody Antibody Response Antibody responses Asymptomatic COVID-19 vaccines declined Dynamics exposure to First wave IgG IgG and IgM IgG ELISA IgG level IgG levels IgG/IgM dynamics IgM individual infected individual Infection investigated Lithuania longitudinal study majority Month outbreak pandemic Reinfection remained S protein SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 S SARS-CoV-2 S protein SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody second wave serological monitoring serological test Serological testing seropositive individual seropositive individuals Seropositivity Severity of infection specific antibodies specific IgM virus-specific antibodies Virus-specific IgG worker [DOI] 10.3390/v13112313 PMC 바로가기 [Article Type] Article